Professional Documents
Culture Documents
TUBERCULOSIS
Santiago, Jillian Mae A.
Objectives
What is TB?
TUBERCULOSIS
Seventy-five (75) Filipinos die
of TB every day, most of them in
the prime of their life.
If untreated, a person with
tuberculosis can transmit the TB
bacteria to as many as 10 to 15
people during the course of one
year, who, in turn, may develop
the disease.
TRANSMISSION
TRANSMISSION
CASE FINDING
CLINICAL PRESENTATION
Presumptive TB Case
Children (<15 years old)
Patient presents at least three of the following clinical signs and symptoms:
Coughing /Wheezing of 2 weeks or more especially if unexplained
Unexplained fever of 2 weeks or more after common causes such as
Malaria or Pneumonia have been excluded
Loss of weight/failure to gain weight/ weight faltering/ loss of appetite
Failure to respond to 2 weeks of appropriate antibiotic therapy for lower
respiratory tract infection
Failure to regain previous state of health 2 weeks after a viral infection or
exanthem
Fatigue reduced playfulness or lethargy
ANY one of the above signs and symptoms (clinical criteria) in a child who
is a close contact of a known active TB case
Presumptive TB Case
Adult ( >=15 years old)
Cough for at least 2 weeks duration with or without following symptoms:
Fever
Hemoptysis
Easy Fatigability
Night sweats
DIAGNOSIS
SPUTUM COLLECTION
SPUTUM RESULTS
SMEAR POSITIVE
Occurs if at least two sputum specimens are AFB (+)
SMEAR NEGATIVE
Occurs if none of the three specimens are AFB (+)
DOUBTFUL
Chest X-ray
Case Holding
The procedure that ensures that patients complete
treatment
assignment
New
A patient who has never had treatment for TB* or who has taken anti-TB drugs for
less than one (<1) month.
Re-treatment
Relapse
A patient previously treated for TB, who has been declared cured or treatment
completed in their most recent treatment episode, and is presently diagnosed with
bacteriologically-confirmed or clinically-diagnosed TB.
Method
developed
to
ensure
treatment
compliance
by
providing
constant
and
motivational supervision to TB patients.
5 Components of TB-DOTS
Program
Category Ia
- New extra-pulmonary TB (CNS/ bones or joints)
Continuation phase - 10 HR
3
Category IIa
- Extra-pulmonary (CNS / bones or joints), previously treated, drug
susceptible TB ( whether bacteriologically-confirmed or clinicallydiagnosed)
Drug Resistant TB
Treatment Outcomes
1. Cured
Was registered as pulmonary smear-positive
completed treatment
becomes smear-negative in the last month of treatment
on at least one previous occasion in the continuation phase.
2 .Completed treatment
registered smear-positive
completed treatment but without DSSM follow-up during the
treatment, or with only 1 negative DSSM during the treatment or
without DSSM in the last month of treatment.
Was registered as pulmonary smear-negative and has completed
treatment.
3. Died
Was known to have died for any reason during the course of
treatment Treatment outcomes
Treatment Outcomes
4. Failed
registered as pulmonary smear-positive, but still smear-positive at 5
months or later during the treatment
registered as smear-negative but becomes smear-positive during the
treatment.
5. Defaulted
Has interrupted treatment for 2 consecutive months or more, and
remained unretrieved.
6. Transferred out
transferred to another health facility for continuation of treatment
with proper referral slip and whose treatment outcome is not
known.
Prevention